In individuals with chronic kidney disease, targeting a systolic blood pressure to <120 mm Hg resulted in lower risks of cardiovascular events and premature death, compared with standard targeting to <140 mm Hg. There was a slightly faster decline in kidney function in the intensive group, but no increase in rates of kidney failure or serious adverse events.